Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$593K Buy
13,905
+416
+3% +$18.6K 0.31% 62
2026
Q1
$650K Sell
13,489
-937
-6% -$43.7K 0.39% 57
2025
Q4
$699K Sell
14,426
-366
-2% -$18.1K 0.45% 53
2025
Q3
$728K Sell
14,792
-390
-3% -$18.8K 0.48% 46
2025
Q2
$733K Buy
15,182
+3,277
+28% +$167K 0.52% 42
2025
Q1
$660K Buy
11,905
+5,212
+78% +$282K 0.54% 37
2024
Q4
$323K Buy
6,693
+16
+0.2% +$814 0.28% 70
2024
Q3
$385K Buy
+6,677
New +$360K 0.37% 64

Other funds holding SNY

Code Waechter's SNY Position: Q2 2026 in Review

Code Waechter increased its Sanofi (SNY) stake by 3.1% in Q2 2026, buying an estimated $18.6K and bringing the position to 13,905 shares worth $593K. The position accounts for 0.31% of the portfolio, ranked #62.

Code Waechter first reported a position in SNY in Q3 2024 and has held it in 8 quarters since. The position peaked at $733K in Q2 2025. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Code Waechter held 13,905 shares of Sanofi worth $593K as of Q2 2026.
  • Code Waechter bought 416 Sanofi shares in Q2 2026, an estimated $18.6K.
  • Sanofi made up 0.31% of Code Waechter's portfolio in Q2 2026, its #62 holding.
  • Code Waechter first reported a position in Sanofi in Q3 2024 and has held it in 8 quarters since.
  • Code Waechter's Sanofi position peaked at $733K in Q2 2025.
  • 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Code Waechter's 13F filing for Q2 2026, filed 31 Jul 2026.